AMAG AMAG Pharmaceuticals Inc

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in an analyst-led fireside chat at the Deutsche Bank 41st Annual Healthcare Conference on Wednesday, May 4, 2016 at 8:40 a.m. ET in Boston. 

A live audio webcast of the discussion will be accessible through the Investors section of the company’s website at www.amagpharma.com.  Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for 30 days.

About AMAGAMAG is a biopharmaceutical company focused on bringing therapeutics to market that provide clear benefits and help improve people’s lives. Headquartered in Waltham, MA, AMAG possesses a diverse portfolio of products to support the health of patients in the areas of maternal health, anemia management and cancer supportive care. Through CBR®, the company also helps families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit www.amagpharma.com.

AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. CBR® is a registered trademark of CBR Systems, Inc.

AMAG Pharmaceuticals Contact: 
Maryann Cimino
Manager, Corporate Communications & External Affairs
617-498-3375